Coming soon. Phase I of this 190-acre new facility is designed for formulation development and manufacture including packaging, labeling and distribution for oral and parenteral drug products including oligonucleotides, peptides and the related synthetic conjugates, expected to start operations in 2026.
Middletown, Delaware, USA
Middletown, Delaware, USA
Formulation development and manufacturing for small molecules, oligonucleotides and peptides
- 1091 Industrial Drive in Middletown Business Center
- +1-973-960-8190
Site Virtual Tour
Site Related News
WuXi STA Breaks Ground for New Pharmaceutical Manufacturing Facility in Middletown, Delaware
MIDDLETOWN, Delaware, August 16, 2022 – WuXi STA, a leading Contract Research, Development, and Manufacturing Organization (CRDMO), is pleased to an...
Read More
WuXi STA Chooses Middletown Delaware for New Pharmaceutical Manufacturing Campus
WuXi STA bringing about 500 jobs to MiddletownWILMINGTON, Del. (June 28, 2021) — WuXi STA and Delaware Prosperity Partnership today announced th...
Read MoreWuXi STA Breaks Ground for New Pharmaceutical Manufacturing Facility in Middletown, Delaware
MIDDLETOWN, Delaware, August 16, 2022 – WuXi STA, a leading Contract Research, Development, and Manufacturing Organization (CRDMO), is pleased to an...
Read MoreWuXi STA Chooses Middletown Delaware for New Pharmaceutical Manufacturing Campus
WuXi STA bringing about 500 jobs to MiddletownWILMINGTON, Del. (June 28, 2021) — WuXi STA and Delaware Prosperity Partnership today announced th...
Read MoreHow can we help?
Oligonucleotide or Peptide Projects?
